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Genetic research has revealed pro-opiomelanocortin (POMC) to be a fundamental regulator of 
energy balance and body weight in mammals. Within the brain, POMC is primarily expressed in 
the arcuate nucleus of the hypothalamus (ARC), while a smaller population exists in the brainstem 
nucleus of the solitary tract (POMCNTS). We performed a neurochemical characterization of this 
understudied population of POMC cells using transgenic mice expressing green fluorescent 
protein (eGFP) under the control of a POMC promoter/enhancer (PomceGFP). Expression of 
endogenous Pomc mRNA in the nucleus of the solitary tract (NTS) PomceGFP cells was confirmed 
using fluorescence-activating cell sorting (FACS) followed by quantitative PCR. In situ hybridization 
histochemistry of endogenous Pomc mRNA and immunohistochemical analysis of eGFP revealed 
that POMC is primarily localized within the caudal NTS. Neurochemical analysis indicated that 
POMCNTS is not co-expressed with tyrosine hydroxylase (TH), glucagon-like peptide 1 (GLP-1), 
cholecystokinin (CCK), brain-derived neurotrophic factor (BDNF), nesfatin, nitric oxide synthase 1 
(nNOS), seipin, or choline acetyltransferase (ChAT) cells, whereas 100% of POMCNTS is co-expressed 
with transcription factor paired-like homeobox2b (Phox2b). We observed that 20% of POMCNTS 
cells express receptors for adipocyte hormone leptin (LepRbs) using a PomceGFP:LepRbCre:tdTOM 
double-reporter line. Elevations in endogenous or exogenous leptin levels increased the in 
vivo activity (c-FOS) of a small subset of POMCNTS cells. Using ex vivo slice electrophysiology, we 
observed that this effect of leptin on POMCNTS cell activity is postsynaptic. These findings reveal 
that a subset of POMCNTS cells are responsive to both changes in energy status and the adipocyte 
hormone leptin, findings of relevance to the neurobiology of obesity. (Endocrinology 161: 1–13, 
2020)
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The rapid rise in the prevalence of obesity has em-phasized the need for a greater understanding of 
the neurobiological mechanisms that underlie energy 
homeostasis and body weight. Circulating nutritional 
cues and neuromodulatory signals are integrated 
within the brain to regulate energy balance. The central 
melanocortin system is a critical point of convergence 
for many of these signals and has a fundamental role 
in regulating body weight. This pathway is comprised 
of the endogenous melanocortin agonists derived from 
POMC, which yield the signaling products α-melanocyte 
stimulating hormone (α-MSH), β-MSH, γ-MSH, adreno-
corticotropic hormone (ACTH), and β-endorphin (1). 
Brain POMC peptides α-MSH, β-MSH, and γ-MSH 
compete for action with the endogenous melanocortin 
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receptor antagonist/inverse agonist agouti-related pep-
tide (AgRP) at melanocortin-3 and -4 receptors (MC3R, 
MC4R) (2), with MC4Rs predominantly linked to en-
ergy balance and body weight regulation (3–5). In the 
adult brain, POMC is expressed in the arcuate nucleus 
of the hypothalamus (POMCARC) and the brainstem nu-
cleus of the solitary tract (POMCNTS) (6, 7). However, 
during development, POMC is transiently expressed 
in at least 60 additional brain regions within cells that 
are not fated to be POMC (8, 9). Accordingly, studies 
employing PomcCRE transgenic approaches may involve 
recombination in off-target sites within the brain and 
peripheral tissues and should be interpreted accordingly.
Brain infusion of α-MSH or synthetic MC4R agon-
ists reduce food intake and body weight, increase energy 
expenditure, and improve glucose homeostasis (10–12). 
Complementing these pharmacological studies, loss-of-
function mutations of Pomc or Mc4r, or over-expression 
of Agrp, promote hyperphagia, obesity, and insulin re-
sistance in multiple species, including zebrafish, mice, 
dogs, and man, illustrating the strong translational 
nature of this system (13–23). Furthermore, genetic 
haploinsufficiency of Pomc/POMC in both rodents and 
humans is associated with preferential over-consumption 
of dietary fat and increased risk for diet-induced obesity 
(DIO) (24, 25). The melanocortin system has therefore 
garnered substantial interest as a potential therapeutic 
target for obesity and the prevention of type 2 diabetes 
(T2D) (26, 27).
Though POMCARC neurons have been well char-
acterized (28, 29), less attention has focused on the 
smaller population of POMC cells localized in the NTS. 
POMCNTS neurons are anatomically localized to impact 
energy homeostasis given that (1) the NTS is a primary 
integrator of multiple metabolic cues (30–34), and (2) 
POMCNTS cell activity is modulated in response to the 
firing of vagal afferent and ingestive-related signals (30, 
31, 35). Indeed, chemogenetic activation of POMCNTS 
neurons results in a suppression of feeding and an en-
hancement of short-term satiety (36). A  recent report 
indicated that POMCNTS is required for the acute an-
orectic effect of obesity medication 5-HT2CR agonist 
lorcaserin (37). However, what has not been established 
is whether other neuropeptides/neurotransmitters im-
plicated in energy homeostasis are co-expressed with 
POMCNTS and the direct endogenous regulators of 
POMCNTS neuron activity.
Specifically, the NTS contains other appetite-
regulating neuropeptides and neurotransmitters such 
as cholecystokinin (CCK) (38, 39), glucagon like pep-
tide-1 (GLP-1) (40, 41), catecholamines (39, 42), brain-
derived neurotrophic factor (BDNF) (43), and nesfatin 
(44). Previous reports indicate that receptors (LepRbs) 
for the adipocyte hormone leptin are co-expressed 
with a subset of POMCNTS neurons using a PomcGFP 
mouse line (43, 45), though others have not found evi-
dence for this using a PomcCRE line (46). In both mice 
and humans, the absence of LepRb/LEPRB leads to 
morbid obesity, hyperphagia, insulin resistance, and de-
creased energy expenditure, amongst other symptoms 
(47–49). Illustrating that the specific subset of LepRb 
co-expressed with brain POMC is involved in this meta-
bolic phenotype, selective inactivation of LepRb only in 
POMC cells produces a milder version of this pheno-
type (50, 51). However, this Cre/Lox approach does not 
distinguish between LepRbs expressed within POMC in 
the ARC or NTS. Here we aimed to clarify the distribu-




Male and female Pomc-enhanced green florescent protein 
(PomceGFP; kindly provided by Prof. Richard Simerly and 
Prof. Malcolm Low) (52), LepRb-Ires-Cre::Rosa26-eGFP 
(LepRbCRE:eGFP) (53) and LepRb-Ires-Cre:tdTOMATO 
(LepRbtdTOM; kindly provided by Prof. Joel Elmquist and Prof. 
Jeffrey Friedman) (54) mice were used. A PomceGFP:LepRbtdTOM 
double-reporter line was produced by crossing homozygous 
PomceGFP and LepRbtdTOM mice. All mice were maintained on 
a 12-hour light, 12-hour dark cycle with ad libitum access to 
a standard laboratory chow diet and water unless indicated 
otherwise. All procedures performed were in accordance with 
the UK Animals (Scientific Procedures) Act, 1986 and with ap-
propriate ethical approval.
Immunofluorescent histochemistry 
Mice were deeply and terminally anesthetized with pento-
barbitone (50  mg/kg i.p.) and transcardially perfused with 
diethylpyrocarbonate (DEPC)-treated phosphate buffered sa-
line (PBS) followed by 10% neutral buffered formalin (Sigma-
Aldrich, Gillingham, UK). Brains were extracted, postfixed in 
10% neutral buffered formalin for up to 6 hours, and then 
cryoprotected through emersion in a 20% sucrose solution in 
PBS for 1–2 days at 4°C. Brains were sectioned at 25 μm on 
a freezing sliding microtome and collected in 5 equal series.
Free-floating NTS sections were washed in PBS and in-
cubated for 1 hour with blocking buffer (2% bovine serum 
albumin with 0.25% Triton X-100 in PBS). Sections were 
then incubated overnight at 4°C in blocking buffer with a pri-
mary antibody: chicken anti-GFP (1:500, Abcam, Cambridge, 
UK [RRID: AB_300798 (55)]), rabbit anti-mCherry 
(1:1000, Rockland Immunochemicals, Limerick, PA [RRID: 
AB_2614470 (56)]), rabbit antinesfatin (1:1000, Phoenix 
Pharmaceuticals, Burlingame, CA [RRID: AB_2737429 (57)]), 
mouse antityrosine hydroxylase (TH; 1:1000, Chemicon, 
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acetyltransferase (ChAT; 1:1000, Millipore, Billerica, MA 
[RRID: AB_2079751 (59)]), rabbit antinitric oxide synthase 
(nNOS; 1:1000, Immunostar, Hudson, WI [RRID: AB_572255 
(60)]), rabbit antiseipin antibody (1:1000, Dr. D.  Ito, Keio 
University School of Medicine, Japan (61, 62) [RRID: 
AB_2819210 (63)]), and rabbit antipaired-like homeobox 
2b (Phox2b; 1:1000, Abcam, Cambridge, UK [RRID: 
AB_10675986 (64)]). The tissue was subsequently washed 
in PBS and incubated for 1 hour with the corresponding sec-
ondary Alexa Fluor antibodies (1:500, ThermoFisher, Paisley, 
UK [RRID: AB_2340375 (65), RRID: AB_141637 (66), 
RRID: AB_141633 (67), RRID: AB_142540 (68)]). Sections 
were mounted onto microscope slides and visualized under an 
Axioskop II microscope (Carl Zeiss, Oberkochen, Germany) 
and images were taken with an AxioCam (Carl Zeiss, 
Oberkochen, Germany) digital camera. Sections containing 
the NTS were assigned a bregma level and boundaries of the 
NTS delineated based on neuroarchitecture and a mouse brain 
atlas (69). The number of PomceGFP immunoreactive (IR) cells, 
neurochemically defined cells, and double-labeled cells falling 
within the defined regions were counted and expressed as a 
percentage of total POMC-eGFP-IR expressing cells in that 
brain slice.
cFOS immunohistochemistry 
PomceGFP mice were injected with mouse recombinant 
leptin (5 mg/kg, i.p., Merck, Whitehouse Station, NJ) or vehicle 
during the light cycle and food was removed. Two hours later, 
mice were deeply anesthetized with pentobarbitone (50 mg/
kg i.p.) and transcardially perfused with DEPC-treated PBS 
followed by 10% neutral buffered formalin. Another cohort 
of PomceGFP mice were fed ad libitum (n = 4), 12-hour fasted 
overnight (n = 5) or 12-hour fasted overnight followed by a 
2-hour light cycle refeeding (n = 5). Mice were then injected 
with deep terminal anesthesia and transcardially perfused with 
DEPC-treated PBS followed by 10% neutral buffered for-
malin. Brains were extracted and tissue prepared as described 
above. Free-floating NTS sections were processed at room 
temperature. Tissue was washed in PBS and then treated for 
30 minutes with 0.3% H2O2 in PBS. Tissue was then washed 
in PBS, blocked for 1 hour in blocking solution (0.25% Triton 
X-100 and 3% normal donkey serum in PBS) and incubated 
overnight in primary antibody rabbit anti-c-fos added to 
blocking solution (cFOS; 1:5000, Calbiochem, Watford, UK 
[RRID: AB_2106755 (70)]). The sections were next incu-
bated in biotinylated donkey antirabbit IgG (1:1000, Jackson 
ImmunoResearch Laboratories, West Grove, PA [RRID: 
AB_2340593 (71)]) for 1 hour, followed by 2-hour incuba-
tion in an avidin–biotin complex solution (1:500, Vectastain 
Elite ABC Kit, Vector Laboratories, Peterborough, UK) diluted 
in PBS. After several washes in PBS, sections were incubated 
in a solution of 0.04% diaminobenzidine tetrahydrochloride 
(DAB) and 0.01% H2O2 in PBS. Brain tissue was then pro-
cessed for GFP immunofluorescent histochemistry (IHC) and 
analyzed as described above. Quantitative analysis of dual-
labeled cells was expressed as a percentage of the total number 
of POMC-eGFP-IR positive cells.
In situ hybridization histochemistry and IHC
In situ hybridization histochemistry (ISHH) was conducted 
as previously described (43). Briefly, mice were injected with 
deep terminal anesthesia and transcardially perfused with 
DEPC-treated PBS followed by 10% neutral buffered formalin. 
Brains were extracted and tissue prepared as described above. 
Radiolabelled riboprobes specific to the mRNA sequences of 
POMC, PPG, BDNF, and CCK were used to detect gene ex-
pression. Linearized recombinant plasmids were subjected to 
in vitro transcription with a T7 RNA polymerase (Ambion 
Inc., Austin, TX) in the presence of 35S-labeled UTP.  cRNA 
riboprobes were diluted to 2  ×  107 cpm/ml in a hybridiza-
tion solution. 35S-labeled Pomc was examined within adjacent 
brainstem sections ranging from -6.36 to -8.24 from bregma of 
2- to 6-month-old male and female wild type C57BL/6 (n = 7) 
and PomceGFP (n = 7) mice. Sections mounted onto microscope 
slides were placed with Carestream Kodak Biomax MR single 
emulsion film (Sigma) in a light tight box for 5 days. Films 
were scanned and manually analyzed, confirming 35S Pomc 
within the NTS. High-resolution images were generated using 
an AxioCam HRc (Carl Zeiss) interface with a brightfield 
Axioskop II microscope (Carl Zeiss).
Following ISHH, free-floating tissue processed for dual-
histochemical staining was washed in PBS before commence-
ment of the IHC protocol. Sections were treated for 30 
minutes in 0.3% H2O2 in PBS, rinsed in PBS, and blocked in 
0.5% BSA/0.5% TritonX-100 in PBS for 1 hour. Sections were 
incubated in blocking buffer containing goat anti-GFP anti-
body (1:1000, Abcam, Cambridge, UK [RRID: AB_304897 
(72)]) overnight. Sections were washed in PBS and a 
biotinylated rabbit antigoat secondary antibody (1:1000, 
Vector Laboratories, Peterborough, UK [RRID: AB_2336126 
(73)]) in blocking buffer for 1 hour. Sections were then washed 
in PBS and incubated for 1 hour in VectaStain ABC reagent 
and chromogenic detection was conducted using DAB re-
agent (Vector Laboratories, Peterborough, UK). Sections were 
mounted onto microscope slides and air dried. Slides were 
dipped in photographic emulsion (Kodak, Rochester, NY) and 
stored at 4°C for 2 weeks before being developed in D-19 de-
veloper and fixer (Kodak). Double-labeled cells were recorded 
if GFP-IR-positive cell bodies contained overlying black grains 
that were in a quantity greater than 3 times the background 
and conformed to the shape of the GFP-IR cell bodies.
Isolation of NTS POMC-GFP cells with FACS
Four-week-old male and female ad libitum–fed PomceGFP 
mice (n = 6) were sacrificed between 9:00 and 10:00 am. The 
NTS was microdissected into ice cold dissociation buffer con-
sisting of 0.36% glucose (Sigma, Gillingham, UK), 2  ×  10-
4% phenol red solution (Sigma), and 1  mM HEPES buffer 
(Sigma) in HBSS solution (Invitrogen, Paisley, UK). 10X Ky/
Mg solution consisting of 0.19% kynurenic acid (Sigma), 
5 × 10-4% phenol red solution (Sigma), 5 mM HEPES buffer 
(Sigma), and 0.1M MgCl2 (Sigma), pH 7.5, was added before 
use. Dissociation media was replaced with 1 ml prewarmed 
20 U/ml papain solution consisting of 20X L-cysteine solu-
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medium (containing 10X Ky/Mg) and nuclei were incubated 
at 37oC for 30 minutes. Papain solution was replaced with 
1 ml prewarmed 10 mg/ml trypsin inhibitor solution (Sigma, 
diluted in dissociation media) and the nuclei incubated at 
37oC for 10 minutes. Trypsin inhibitor was removed and nu-
clei were washed with 1  ml ice cold PBS (Sigma) with 2% 
FCS (P.A.A.  laboratories, Ltd., Yeovil, UK). Phosphate buf-
fered saline was replaced with 2 ml PBS with 2% FCS and the 
solution triturated. Samples were filtered through a 70 µm cell 
strainer (BD Falcon, Tewksbury, MA). Fluorescence-activating 
cell sorting was performed using an Influx Cell Sorter (BD 
Biosciences, San Jose, CA) utilizing a previous established 
method (31, 32). Cell gating was set according to cell size 
(FSC), cell granularity (SSC), FSC pulse-width for singlets, 
and fluorescence at 488 nm/532 nm for GFP and 647/670 nm 
for nuclear stain with DraQ7 (Biostatus, Shepshed, Leicester, 
UK). Pools of GFP-positive (GFP+) and GFP-negative (GFP-) 
cells were sorted into a plate containing RLT lysis buffer 
(Qiagen, Manchester, UK) and RNA was isolated using RNeasy 
Plus Micro Kit (Qiagen). Reverse transcription and whole 
transcriptome amplification were performed using Nugen 
Ovation Pico WTA system V2 following the manufacturer’s 
instructions. Pomc expression was determined by quantitative 
real-time PCR (qPCR) using Sybr green with primers designed 
specifically for Pomc (Forward CTCCTGCTTCAGACCTCCAT, Reverse- 
TTTTCAGTCAGGGGCTGTTC), Gfp (Forward- AGCCGCTACCCCGACCACAT, 
Reverse- CGGTTCACCAGGGTGTCGCC). Gene expression was 
normalised to Gapdh (Forward- TGTTCCTACCCCCAATGTGT, Reverse- 
GGTCCTCAGTGTAGCCCAAG) in the same samples.
Electrophysiology
Standard current and voltage clamp whole-cell patch clamp 
electrophysiology recordings were made from POMCNTS 
cells. Specifically, PomceGFP mice (6–10 weeks old) were in-
jected with a terminal dose of pentobarbitone (50 mg/kg, i.p.), 
decapitated, brains rapidly extracted, and immediately sub-
merged in an ice-cold solution containing 250 mM sucrose, 
2.5 mM KCl, 21 mM NaHCO3, 1.2 mM NaH2PO4, 3 mM glu-
cose, 4 mM MgCl2, and 0.1 mM CaCl2 bubbled with 5% CO2 
and 95%O2. The brain was fixed to a vibrating microtome 
(Slicer HR2; Sigmann Elektronik, Hüffenhardt, Germany) and 
180 μm coronal sections of the brainstem containing the NTS 
were prepared. The slices were then incubated for 25 minutes 
at 34°C in oxygenated artificial cerebral spinal fluid (aCSF) 
containing 125 mM NaCl, 2.5 mM KCl, 21 mM NaHCO3, 
1.2 mM NaH2PO4, 3 mM glucose, 2 mM MgCl2, and 2 mM 
CaCl2. Prior to recording, slices were allowed to recover in 
the aCSF solution at room temperature for a minimum of 1 
hour. Green fluorescent protein cells in live slices were identi-
fied using a Nikon Eclipse E6000FN microscope fitted with an 
LED light source (Cairn, Edinburgh, UK). During recording, 
unless otherwise described, slices were continuously per-
fused at a rate of ca. 2 ml/min with oxygenated aCSF solu-
tion at 31°C. Leptin was bath applied. Thick-walled glass 
pipettes (Harvard Apparatus, Holliston, MA) of 4 to 5 MΩ 
resistance were pulled using a Zeitz DMZ micropipette puller 
(Zeitz Instruments GmBH, Martinsried, Germany). Pipettes 
were filled with the following intracellular solution: 120 mM 
K-gluconate, 10 mM KCl, 0.1 mM EGTA, 10 mM HEPES, 
4  mM K2ATP, and 1  mM Na2ATP at pH 7.3 (with KOH). 
Recordings were performed using an EPC10 amplifier and 
Patchmaster software (HEKA, Lambrecht/Pfalz, Germany). 
Where indicated, the following combination of neurotrans-
mission inhibitors was used: 1 μM tetrodotoxin (TTX), 3 μM 
strychnine, 50 μM picrotoxin, 50 μM D-AP5, 10 μM CNQX. 
Liquid junction potential was 10 mV and not compensated. 
The recorded current was sampled at 10 kHz and filtered at 
5 kHz unless otherwise stated. No effect was set as a change in 
membrane potential less than 2 mV. All compounds were dis-
solved in water with the exception of picrotoxin, which was 
dissolved in ethanol.
Leptin ELISA
Animals were terminally anesthetized with pentobarbitone 
(50  mg/kg, i.p.). The blood was collected in EDTA-coated 
tubes (Startedt AG & Co., Numbrecht, Germany). To separate 
plasma, whole blood was centrifuged at 3500  rpm for 15 
minutes at 4°C. Leptin concentrations in serum samples was 
determined using Mouse Leptin Quantikine® ELISA (R&D 
Systems, Abington, UK) according to the manufacturer’s 
protocol at room temperature. Briefly, the kit equilibrated for 
30 minutes at room temperature. Assay diluent RD1W (50 μl) 
and sample (50 μl) were added to the 96-well microplate. Next, 
working leptin standards and leptin controls were added and 
the plate was covered for 2 hours. Each well was aspirated and 
washed (5x) with 400 μl wash buffer. Mouse leptin conjugate 
(100 μl) was added to each well and the plate was incubated 
for 2 hours. The washing step was repeated. Substrate solu-
tion (100 μl) was added to each well and the plate, and the 
plate was covered to protect it from light exposure and left 
for 30 minutes. Finally, the reaction was stopped by adding 
100 μl of stop solution, initiating a color change from blue to 
yellow. The plate was mixed by gentle tapping and the absorb-
ance was then measured within 30 minutes on an EnVision® 
2104 Multilabel Plate Reader (Perkin Elmer, Waltham, MA), 
measuring the absorbance at 450 nm and subtracting the ab-
sorbance at 540 nm/570 nm. The serum leptin levels in each 
group were determined using the standard curve obtained 
from the leptin standards provided.
Statistics
Data were analyzed with t-test or one-way ANOVA fol-
lowed by Tukey’s post hoc tests, where appropriate. For all 
analyses, significance was assigned at P < 0.05. Data are pre-
sented as mean ± SEM.
Results
Pomc mRNA and PomceGFP distribution in the 
NTS
POMC is an essential regulator of energy homeo-
stasis and body weight, and POMC neurons within the 
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are also localized within the NTS. Using in situ hybrid-
ization with a 35S Pomc riboprobe, endogenous Pomc 
mRNA expression was visualized within the NTS of 
wild-type male and female mice on a C56BL/6 back-
ground (n = 7) and PomceGFP mice (n = 7). 35S Pomc 
within the NTS was most abundant between -7.5 to -7.8 
from bregma (Fig. 1A and 1B). Scattered cells were also 
evident at more rostral and caudal levels. POMCNTS has 
likely received less attention compared to POMCARC 
because this NTS  subpopulation is smaller and more 
difficult to visualize on a single cell level with standard 
histochemical techniques, as we have observed here. 
To overcome these technical difficulties we employed a 
PomceGFP reporter mouse line to map the distribution of 
individual POMC cells within the brainstem. Expression 
of GFP protein confirmed that the majority of brainstem 
POMC cells sit within caudal NTS (-7.5 to -7.8 from 
bregma; Fig. 1C).
NTS validation of PomceGFP mouse line
To confirm the expression of Pomc mRNA within 
eGFP cells, the NTS was microdissected from PomceGFP 
mice (n  =  6), and FACS followed by Pomc and Gfp 
qPCR was performed (Fig. 1D). One-hundred percent 
Figure 1. POMCNTS expression and PomceGFP validation. A: Adapted brain atlas (69) schematics of NTS (shaded green area) at -7.56 to -7.76 from 
bregma. B: In situ hybridization histochemistry (ISSH) with a 35S-labelled Pomc riboprobe revealed the highest level of Pomc mRNA (black grains) 
within the NTS is between -7.5 to -7.8 from bregma in adult wild-type C57BL/6 mice (n = 7). These findings were reproduced in PomceGFP mice 
(n = 7). C: Representative photomicrographs of GFP immunofluorescence (IF) in adult male and female PomceGFP mice (n = 20) also identified that 
the most abundant distribution of GFP-IR cells is between -7.5 to -7.8 from bregma. D: Expression of Pomc mRNA in GFP cells in extracted NTS of 
PomceGFP mice was confirmed using fluorescence-activating cell sorting (FACS) followed by qPCR analysis. Pomc and Gfp mRNA were normalized to 
that of the housekeeping gene Gapdh. Expression of Pomc and Gfp mRNA is expressed as a percentage of that determined in GFP-positive (GFP+) 
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of GFP-positive cells expressed Pomc mRNA as com-
pared to 8% of GFP-negative cells. Similarly, 99% of 
GFP-positive cells expressed Gfp mRNA as compared 
to 10% of GFP-negative cells. These data provide the 
first NTS validation of the PomceGFP line and verify the 
expression of endogenous POMCNTS.
Neurochemical characterization of POMCNTS 
neurons
The NTS has a regulatory role in a large number 
of physiological processes. As a consequence of this 
functional heterogeneity, this nucleus is home to nu-
merous distinct neuronal populations. To characterize 
POMCNTS cells, we examined the level of co-expression 
between PomceGFP and other neurochemicals and re-
ceptors implicated in the regulation of energy balance. 
We observed that POMCNTS cells do not co-localize 
with catecholamines epinephrine or norepinephrine 
using TH to visualize this subset of cells (Fig.  2A). 
Similarly, PomceGFP was not co-expressed with the 
neuropeptide nesfatin-1 (Fig.  2B) or the neurotrans-
mitter acetylcholine using choline acetyltransferase 
(ChAT; Fig.  2C). PomceGFP was expressed in a dis-
tinct population to the protein seipin associated with 
lipodystrophy (Fig.  2D) and the enzyme nitric oxide 
synthase 1 (nNOS; Fig.  2E). Likewise, PomceGFP was 
not co-localized with neuropeptides involved in the re-
duction of food intake, preproglucagon (PPG)/GLP-1 
Figure 2. Neurochemical characterization of POMCNTS neurons. Immunohistochemical analysis of adult male and female PomceGFP mice 
demonstrated GFP-IR cells (green) to be negative for catecholamine cell marker tyrosine hydroxylase (TH)-IR (red) (A), nesfatin-IR (red) (B), 
acetylcholine cell marker choline acetyltransferase (ChAT)-IR (red) (C), protein seipin-IR (red) (D) and enzyme nitric oxide synthase 1 (nNOS)-IR 
(red) (n = 3–5 mice per analysis) (E). Dual IHC and ISHH analysis of adult male and female PomceGFP mice demonstrated the absence of GFP-IR 
co-expression (brown cytoplasmic stain) with 35S preproglucagon (Ppg) (F), 35S cholecystokinin (Cck) (G) or 35S brain derived neurotrophic factor 
(Bdnf) mRNA (black grains) (n = 3–5 mice per analysis) (H). I: Double-IF analysis in adult male and female PomceGFP:LepRbCre:tdTomato mice (n = 9) 
revealed a subset of POMC-expressing neurons (green) were co-expressed with LepRb-expressing cells (red). J: In PomceGFP mice (n = 4) and 
LepRbCRE:eGFP mice (n = 4) (K), all GFP-IR cells (green) were Phox2b-IR positive (red). L: Schematic illustrating overlap of POMC, Phox2b, and LepRb 
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(Fig.  2F), CCK (Fig.  2G), or BDNF (Fig.  2H), as re-
vealed with immunohistochemistry combined with in 
situ hybridization. Thus, PomceGFP neurons appear to 
reside in a distinct subgroup within the NTS and do not 
co-express other well-characterized regulators of energy 
homeostasis.
We then examined potential endogenous regulators 
of POMCNTS. Some previous reports indicate that 
leptin administration increases a marker of leptin signal 
transduction (pSTAT) in PomceGFP cells (45), thereby 
providing evidence of co-localization. To facilitate the 
visualization of POMC and LepRb cells and to quan-
tify co-expression, we crossed LepRbtDTomato mice 
with  PomceGFP mice to create a double reporter line 
(PomceGFP:LepRbtdTomato). We found that 20.6% ± 2.14 
of POMCNTS cells co-localized with LepRbtdTomato 
(Fig.  2I). Co-localization was highest at -7.64 and 
-7.76 from bregma, the subregion of the NTS we found 
to express the majority of POMC cells (Fig.  1C). All 
PomceGFP cells co-expressed Phox2b, a transcription 
factor associated with the formation and development 
of the NTS (74) (Fig.  2J). Using LepRbCRE:eGFP mice 
to visualize LepRbNTS expression, we observed that all 
LepRbNTS cells also expressed Phox2b (Fig. 2K and 2L).
PomceGFP cells increase their activity in response 
to food intake
Given that a subset of POMCNTS cells co-express 
LepRb, we postulated that this subgroup should be 
responsive to leptin. Fasting has been shown to affect 
the concentrations of various circulating hormones, 
including reducing leptin (75). We dark cycle fasted 
mice, dark cycle fasted and then re-fed mice, or ad lib-
itum fed mice and measured serum leptin and the ac-
tivity of POMCNTS cells using FOS-IR (Fig.  3). The 
NTS and blood was collected 2 to 4 hours following 
the onset of the light cycle. As expected, fasting signifi-
cantly reduced leptin levels (0.56 ± 0.30 ng/ml, n = 4) 
and fasting followed by a 2-hour bout of refeeding sig-
nificantly increased leptin levels (3.44  ±  0.82  ng/ml, 
n = 8; F2,19 = 4.64, P = 0.023; Fig. 3E). A significant dif-
ference in leptin levels between the refed group and the 
fed group (1.58 ± 0.32 ng/ml, n = 9) was not detected. 
Refeeding (n = 9) also significantly increased the number 
of FOS-IR-positive cells within the NTS compared to 
the fasted state or fed state (Fig. 3E). Significantly more 
NTS PomceGFP neurons expressed FOS-IR in mice that 
had been fasted and then refed (21.34 ± 6.91 cells) com-
pared to mice in the fasted (0.93  ±  0.42 cells) or fed 
state (1.29 ± 0.54 cells; F2,11 = 7.55, P = 0.008, n = 4–5 
per group; Fig. 3A–3D). These findings suggest that a 
subset of POMCNTS cells are responsive to nutritional 
state and changes in hormones such as endogenous 
leptin levels.
Leptin activates a subset of POMCNTS neurons
To gain further insight into the physiological role 
of the LepRb expression on POMCNTS cell activity, 
we examined the effect of peripheral administration of 
leptin. Consistent with the fluctuations of endogenous 
leptin described above, we observed that leptin (5 mg/
kg, i.p.) increased FOS-IR within the NTS compared to 
saline treatment (Fig. 4A). We examined the effect specif-
ically in POMCNTS cells and found that leptin increased 
Figure 3. PomceGFP cells increase their activity in response to food intake. A-D: PomceGFP mice exhibit more FOS-IR in GFP-IR cells within the NTS 
in response refeeding compared to cells from mice in the ad libitum–fed or 12-hour fasted state (n = 4–5). E: Endogenous plasma leptin levels are 
increased following refeeding (n = 8) compared to ad libitum–fed (n = 9) or 12-hour fasted mice (n = 4) as measured by an ELISA assay. Level of 
NTS presented in (A–C), -7.76 from bregma. Arrows represent dual-labeled cells. CC, central canal. Scale bar, 50 μm applies to (A–C). Scale bar in 
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Figure 4. PomceGFP cells are responsive to changes in exogenous leptin levels. A–C: Leptin treatment (5 mg/kg, i.p.) in PomceGFP mice increased 
FOS-IR within GFP-IR (A–B) and non-GFP-IR NTS cells (C) compared to saline treatment (n = 10). Level of NTS presented in A, -7.56 to -7.76 from 
bregma. D: Representative current clamp recording of a PomceGFP cell. E–F: Bath application of leptin (100–250 nM) increased the membrane 
potential of 4 out of 10 PomceGFP cells and reduced the membrane potential of 1 cell. G: Representative current clamp recording of a PomceGFP cell 
in the presence of synaptic blockers (1 μM tetrodotoxin, 3 μM strychnine, 50 μM picrotoxin, 50 μM D-AP5, 10 μM CNQX). H–I: Bath application of 
leptin (250–500 nM) depolarised and increased the membrane potential of 7 of 30 PomceGFP cells and inhibitory effects were observed in 3 cells. 
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FOS-IR within POMC-eGFP-IR cells compared with sa-
line (t(8) = 4.44, P = 0.001, n = 5 per group; Fig. 4B). 
However, leptin also increased FOS-IR in chemically 
undefined NTS cell populations. Only 2.37% of FOS-
IR-positive cells were POMC-eGFP-IR (Fig. 4C).
To examine the leptin-associated activation of 
POMC-eGFP-IR cells further, we measured the effect 
of leptin on the electrical activity of POMCNTS cells ex 
vivo. Bath application of leptin (100–250 nM) increased 
the firing rate of 40% of POMC neurons (6.00 ± 1.67 
mV vs. -0.36 ± 0.55 mV, t(8) = 3.98, P = 0.005, n = 4/10 
cells; Fig.  4D–4F). This effect was postsynaptic, as 
the depolarization persisted in the presence of syn-
aptic blockers (3.33  ±  0.61 mV vs. -0.41  ±  0.20 mV, 
F2,27 = 41.61, P < 0.0001, n = 7/30 cells; Fig. 4G–4I). 
The in vivo and ex vivo data highlight that a subset of 
PomceGFP neurons in the NTS respond to leptin.
Discussion
Obesity has emerged as a key challenge to human health, 
making it essential that the neurobiology underpinning 
energy homeostasis is clarified to foster the identifica-
tion of new strategies to prevent and treat this condi-
tion. Genetic analysis has revealed that a functioning 
melanocortin system is necessary for healthy body 
weight in multiple species. Specifically, genetic disrup-
tion of POMC/Pomc and MC4R/Mc4r promotes severe 
hyperphagia and obesity (76). Within the adult brain 
POMC is predominantly expressed within the ARC, and 
the function of POMCARC has been extensively charac-
terized. Here we investigated the smaller and less well-
studied population within the NTS.
Distribution of POMCNTS
Low levels of endogenous Pomc expression within 
the NTS have hampered the study of this subpopulation. 
To overcome these technical restrictions, we utilized a 
reporter mouse line that allowed us to map, quantify, 
and characterize these cells. Here we provide an in-
strumental validation of the expression of endogenous 
Pomc mRNA in eGFP cells in the PomceGFP mouse line. 
We report that POMCNTS cells are primarily localized 
within the commissural NTS at the level of the AP. 
Though other energy balance modulating neurons are 
present within the caudal DVC, we observed a lack of 
co-localisation with CCK, GLP-1, TH, BDNF, nesfatin, 
nNOS, seipin, or ChAT-containing cells. POMCNTS cells 
are activated by visceral afferents and chemogenetic ac-
tivation of POMCNTS decreases acute food intake and 
produces opioid analgesia and bradycardia (30, 36, 
77). This suggests that POMCNTS cells may constitute 
a distinct hub within the hindbrain for the regulation 
of food intake via peptide product α-MSH and for the 
induction of analgesia via peptide product β-endorphin. 
The melanocortin system also appears to play a role 
in blood pressure and heart rate. Compared to equally 
obese control subjects, the prevalence of hypertension 
in MC4R-deficient people was significantly lower, and 
MC4R-deficient patients exhibited lower increases in 
heart rate upon waking (78). Though lacking direct 
co-expression, POMCNTS cells may form local inter-
actions with neighboring DVC TH, GLP-1, CCK, BDNF, 
nesfatin, nNOS, seipin, and/or ChAT cells to impact 
homeostasis, analgesia, and/or blood pressure.
In support of system connectivity, CCK increases 
the firing rate of POMCNTS cells (30). Though CCK is 
widely expressed within the CNS, recent reports sup-
port a functional role of the subpopulation of CCK-
positive neurons within the NTS in feeding behavior 
and body weight regulation. Specifically, chemogenetic 
or optogenetic activation of CCKNTS neurons potently 
reduces food intake and body weight (38, 39). This ef-
fect appears to be mediated via transmitter release in 
the paraventricular nucleus of the hypothalamus (PVH) 
and parabrachial nucleus (PBN) given that selective 
optogenetic activation of CCKNTS axon terminals 
within these regions reduces feeding (38, 39). A subset 
of CCKNTS cells co-express PPG/GLP-1 (43). Like 
CCKNTS, chemogenetic activation of PPG/GLP-1NTS 
cells also suppresses acute feeding (41).
Nesfatin-1 is a peptide and neuropeptide first iden-
tified in 2006 and observed to reduce food intake (79). 
NesfatinNTS cells are responsive to CCK-8 and gastric 
distention (80–82). It is therefore possible that CCKNTS 
not only impacts feeding via a PVH and PBN circuit, but 
also via a local interaction with nesfatin and POMC. 
Providing support for potential cardiovascular function, 
NTS microinfusion of nesfatin-1 increases blood pres-
sure and heart rate (80). A subset of NesfatinNTS cells 
co-express GABA and the majority of the dorsal motor 
nucleus of the vagus (DMX) nesfatin cells co-express 
ChAT. NesfatinDMX cells innervate the stomach (80).
One of the best described cell types within the NTS 
modulating feeding behavior are those expressing the 
catecholamines. Similar to our findings, Fan and col-
leagues reported no overlap between the expression of 
POMC and TH in the NTS (31). Like POMCNTS cells, 
vagal afferents also directly innervate THNTS cells (83) 
and similar to nestfatinNTS, THNTS are responsive to gas-
tric distension (84). Direct chemogenetic or optogenetic 
activation of noradrenergic dopamine β-hydroxylase 
(DBH)-expressing NTS neurons also decreases food in-
take and body weight (39). Supporting a cardiovascular 
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but not the neurotoxin 6-hydroxydopamine (6-OHDA) 
infused into the NTS, causes myocardial lesions and in 
some cases sudden death (85, 86).
As observed in POMC deficiency, genetic alterations 
in BDNF in humans is linked to elevated food intake 
and obesity (87, 88). BDNF function is best charac-
terized within the ventromedial hypothalamus (VMH) 
(89). BDNF signaling within the NTS is essential to life, 
as the knockout of its receptor TrkB within the NTS is 
lethal (90). Heterozygous mice with partial knockdown 
are hyperphagic but display a normal body weight (90). 
Additional research is required to define a function for 
BDNFNTS.
Despite being known primarily for its role in adi-
pocyte differentiation, the protein seipin is expressed 
within the NTS; however, its function within this region 
has yet to be fully explored (62). nNOS plays a role in 
a variety of processes, including blood pressure, energy 
homeostasis, and synaptic plasticity. Viral knockdown 
of nNOSNTS in rats inhibited sympathetically mediated 
baroreflex (91), though food intake and body weight 
in these rats was not reported and remains to be in-
vestigated. Thus, the NTS harbors a variety of factors 
involved in homeostatic regulation and future study is 
warranted to unpick potential local interactions and 
their functional implications.
Though POMCNTS cells do not co-express CCK, 
GLP-1, TH, BDNF, nesfatin, seipin, or nNOS, 100% of 
POMCNTS co-express Phox2b. Phox2b is a transcrip-
tion factor that is required for the embryonic develop-
ment of the autonomic nervous system. The Phox2bCRE 
line is frequently used as a broad NTS histochemical 
marker or to genetically alter cells within the NTS. 
Functionally, subsets of Phox2b cells have been re-
ported to be involved in central excitatory relays of the 
sympathetic baroreflex and transmit peripheral chemo-
receptor information to the retrotrapezoid nucleus (92, 
93). Moreover, a recent study revealed that a subset of 
Phox2bNTS neurons act as central respiratory chemo-
receptors (94).
Modulation of POMCNTS
In line with previous findings (31), we observed that 
the activity (as detected by FOS-IR) of a small subset 
of POMC-eGFPNTS cells is activated by a feeding bout. 
In the present report, we employed an acute fast fol-
lowed by 2 hours of refeeding. In the earlier report, 
PomceGFP mice were on a restricted feeding schedule 
of 5 hours per day (31). The proportion of POMCNTS 
cells activated following refeeding was greater than 
that observed in response to leptin treatment, sug-
gesting that other homeostatic factors modulate the ac-
tivity of POMCNTS cells. We found that POMCNTS cells 
expressing LepRbs were primarily concentrated -7.56 to 
-7.92 from bregma, an area where POMC neurons have 
been shown to respond to dietary amino acids (95, 96). 
A study by Grill and colleagues provides support that 
LepRbs within the NTS are required for appropriate en-
ergy homeostasis (97). Specifically, they observed that 
viral knockdown of LepRb within the NTS increased 
food intake, body weight, and adiposity in rats. Phox2
bCRE:LepRbflox’d mice were hyperphagic, displayed in-
creased food intake after fasting, and gained weight at 
a faster rate than wild-type controls. Phox2bCRE:LepRb
flox’d mice also exhibited an increased metabolic rate in-
dependent of changes in locomotor activity and normal 
glucose homeostasis (98). These data suggest that 
leptin signaling within the NTS is required for normal 
feeding and body weight in rodents and that a subset of 
POMCNTS cells are regulated by leptin.
In line with other earlier work, we observed in-
creased FOS-IR in a subpopulation of POMCNTS cells 
following acute leptin treatment (45, 99). However, 
our results do not coincide with similar experiments 
utilising a PomcCRE-driven reporter line (46). As the 
PomceGFP and the PomcCRE reporter lines appear to 
label nonoverlapping neuronal populations within the 
NTS (8), it is likely that the cells characterized here and 
in references 45 and 99 represent a different population 
to those studied in reference 46. To further investigate 
the mechanism by which POMCNTS neurons respond 
to leptin, we employed whole cell patch clamp electro-
physiology. Leptin’s effects on neuronal excitability in 
the rat brainstem are varied and appear to encompass 
cells that are inhibited, excited, or nonresponsive (100, 
101). Approximately half of the unidentified neurons 
described in these studies became hyperpolarized upon 
leptin application, while a smaller proportion (13%) 
showed an increase in membrane potential (100, 101). 
We provide some of the first insights into the effect of 
leptin on PomceGFP cells. We found that leptin increased 
the firing rate of approximately a quarter of PomceGFP 
cells, a pattern similar to the proportion of POMCNTS 
FOS-IR-positive cells. As the membrane potential in-
crease endured in the presence of synaptic blockers, we 
conclude that POMCNTS cells possess the required cel-
lular machinery to respond directly to circulating levels 
of this hormone. However, the effects observed were 
small and warrant further investigation with different 
concentrations of leptin and different electrophysio-
logical techniques to further clarify both the network 
and direct effects of leptin on PomceGFP cell activity. 
TRPC channels are responsible for the activation of 
POMCARC neurons by leptin (102). The precise electro-
physiological mechanism and the current responsible 
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We recently reported that approximately 40% of 
POMCNTS cells co-express the 2c receptor subtype 
for the neurotransmitter serotonin (5-HT2CR) (37). 
Moreover, we observed that POMCNTS is essential for 
the appetite suppressive effects of the 5-HT2CR obesity 
medication lorcaserin (37). The findings reported here 
add to the profile of POMCNTS and its potential physio-
logical role. Specifically, we dissect the interplay of 2 of 
the most essential players in body weight regulation, the 
melanocortin and leptin systems, within the key homeo-
static brain region the NTS. We reveal that POMCNTS 
cells represent a segregated class of leptin responsive 
neurons that do not co-localize other established NTS 
metabolic regulators. These findings provide new in-
sights into the neuroendocrinology of appetite and have 
implications for the neurobiology of obesity.
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